abstract |
The present invention is represented by the formula (I): R 1 -AVVBR 2 , wherein V is phenyl or a 6-membered heteroaryl ring containing up to 3 N atoms. Or a pharmaceutically acceptable salt thereof is an agonist of GPR116 and is useful in the treatment of obesity and diabetes. |